Anika Therapeutics has patented a system and method for a non-binding allograft subtalar joint implant for foot surgery. The implant maintains anatomical alignment and reduces abnormal motion between bones. The method involves selecting spacers based on fit evaluation and using pre-formed allograft rod plugs. GlobalData’s report on Anika Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Anika Therapeutics, was a key innovation area identified from patents. Anika Therapeutics's grant share as of April 2024 was 56%. Grant share is based on the ratio of number of grants to total number of patents.
Non-binding allograft subtalar joint implant system and method
A recently granted patent (Publication Number: US11944550B2) outlines a method for providing a non-binding allograft into a joint within a patient. The method involves surgically accessing the joint, selecting a spacer based on fit evaluation, and disposing it within the joint. If the fit is undesirable, a second spacer with a different diameter is selected and evaluated. Conversely, if the fit is desirable, a pre-formed allograft rod plug is chosen and inserted into the joint. The method includes steps for re-evaluating range of motion and ensuring anatomical alignment post-insertion.
The patent also details the process of selecting and preparing the pre-formed allograft rod plug, which involves harvesting dermis elements from donors, processing them to remove cellular components, rolling them into rods, cutting them into lengths, freeze-drying, and packaging. The method is applicable to joints in the hand or foot, with specific steps for insertion using guide wires and delivery cannulas. The pre-formed allograft rod plug is designed to be resiliently compressible and flexible, maintaining correct joint alignment and reducing abnormal motion between adjacent bones. The patent emphasizes the importance of evaluating fit and range of motion post-insertion to ensure successful joint function before closing surgical access to the joint.
To know more about GlobalData’s detailed insights on Anika Therapeutics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
